4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-23-000009
Director sold 3,070 shares at $798.42 ($2,451,149)
- Director acquired 3,070 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BROWN MICHAEL S · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,070 | $520.01 | $1,596,431 | 4,317 | D |
| 2023-04-21 | Sale : show line 2 in the form 10b5-1 | −3,070 | $798.42 | $2,451,149 | 1,247 | D |
| Open-market sales · 3,070 sh · avg $798.42 · $2,451,149 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-21 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −3,070 | 0 | D |
Loading xslF345X04/edgardoc.xml…